ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.080
+0.100 (2.51%)
At close: Oct 3, 2025, 4:00 PM EDT
4.080
0.00 (0.00%)
After-hours: Oct 3, 2025, 6:30 PM EDT

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $18.84M in the quarter ending June 30, 2025, with 8.21% growth. This brings the company's revenue in the last twelve months to $77.25M, up 15.73% year-over-year. In the year 2024, ADC Therapeutics had annual revenue of $70.84M with 1.84% growth.

Revenue (ttm)
$77.25M
Revenue Growth
+15.73%
P/S Ratio
5.70
Revenue / Employee
$291,494
Employees
265
Market Cap
459.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202470.84M1.28M1.84%
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.